DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Baird Maintains Outperform on Syndax Pharmaceuticals, Raises Price Target to $27

Baird maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Outperform and raises the price target from $20 to $27.

Benzinga · 03/04/2020 14:19

Baird maintains Syndax Pharmaceuticals (NASDAQ:SNDX) with a Outperform and raises the price target from $20 to $27.